Pharmaceutical PV DIV - FSB
Ended Awarded
- Contract number
- SPE2DU26FB795
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $64,811
Award facts
- Contract value 100% obligated
- $64,810.88 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $64,810.88, was awarded on November 20, 2025, to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) for pharmaceutical supply and distribution services. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award to this major pharmaceutical distributor. As a child contract under DLA's broader pharmaceutical procurement framework, this delivery order is one of multiple transactions issued against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026 that serves as the primary global pharmaceutical support mechanism for military healthcare systems.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a critical vendor for federal medical procurement, supplying a comprehensive portfolio of pharmaceutical products and medical commodities including brand-name and generic medications, vaccines, specialty treatments, and medical devices across multiple therapeutic domains. The company's federal contract performance demonstrates capability to meet military and veteran healthcare system requirements through the DLA Medical Supply Chain. This delivery order supports the Defense Logistics Agency's mission to sustain pharmaceutical availability for Department of Defense healthcare operations, with ultimate completion targeted for November 20, 2025.
Quick answers
Who was awarded contract SPE2DU26FB795?
SPE2DU26FB795 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 20, 2025.
How much is contract SPE2DU26FB795 worth?
The government has obligated $64,811 on SPE2DU26FB795.
Is contract SPE2DU26FB795 an order under another contract?
Yes. SPE2DU26FB795 is a delivery order under SPE2DU25D4211, an indefinite delivery contract.
Was contract SPE2DU26FB795 competed?
The extent of competition for SPE2DU26FB795 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award